Success Story: EB-1A Approved for a Research Fellow in Cardiovascular Research Without an RFE
Client’s Testimonial:
"Many thanks for handling my I-140 application. I am sincerely grateful for your outstanding service, as you made the entire process seamless and effectively addressed all my queries and concerns. Your firm truly lived up to its esteemed reputation, which had been highly recommended by my colleagues.”
On March 5th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Cardiovascular Research (Approval Notice).
General Field: Cardiovascular Research
Position at the Time of Case Filing: Research Fellow
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: March 5th, 2026
Processing Time: 29 months, 1 day
Case Summary:
Cardiovascular disease is the leading cause of death in the United States, and the scientific community's ability to address it depends critically on researchers who can bridge fundamental molecular biology with clinical relevance. Holding a Ph.D. in life sciences, the client is currently working as a research fellow in the field of cardiovascular research. Across a sustained and diverse research record, the expert has consistently produced findings that independent researchers around the world reach for when building their own studies.
The petition was supported by 4 expert recommendation letters. One expert noted:
"Considering the benefits of [Client]’s research, it is important that [Client] be permitted to continue [Client]’s work in the United States."
For EB-1A, the most persuasive cases are built not around isolated accomplishments but around a demonstrable pattern of sustained influence: independent researchers repeatedly building on the work, top-tier venues consistently accepting it, and the field's most selective journals trusting the researcher to evaluate submissions.North America Immigration Law Group (NAILG) organized the filing around those behavioral signals, documenting that the client's impact was not concentrated in a single paper or project but reflected across a sustained and diverse body of cardiovascular research. We structured the evidence so USCIS could verify impact through clear objective indicators:
- Peer-review activity: at least 50 completed reviews for distinguished journals in the field
- Publication record: 15 peer-reviewed scientific articles published
- Citation reliance: 353 citations
- Funding sources: National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Defense Research and Development Organisation (DRDO), Department of Science and Technology (DST), Indian Council of Medical Research (ICMR), and the Canadian Institutes of Health Research (CIHR)